ClinicalTrials.Veeva

Menu

Analysis of Suicidal Behavior Among Children and Adolescents in the Auvergne-Rhone-Alpes Region During the Covid 19 Pandemic Period (TSPedCovid)

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Not yet enrolling

Conditions

Suicidality
COVID -19

Treatments

Other: Aggregated data collection
Other: Data collection and qualitative interview

Study type

Interventional

Funder types

Other

Identifiers

NCT07302295
2023-A02237-38 (Other Identifier)
69HCL22_1175

Details and patient eligibility

About

In 2020, the world is hit by a global health crisis due to a pandemic following the appearance of Sars-cov-2 or "covid-19". This pandemic was accompanied by a constant fear of contamination and death, relayed by the media. In France, the government proposed in response to the arrival of this virus on French territory. This policy was implemented in different ways over 3 distinct periods: strict containment at the start of the epidemic, then a "lighter" one, and finally a period of social restrictions without between these periods. This policy had a direct and rapid impact on the population's daily routines. Children and adolescents, are more susceptible to psychological trauma, as stress has a direct and psychic development. Studies have shown deleterious impact of the French health situation on the paediatric population. They point to an increase of psychological disorders such as depression and anxiety in the under -20s population, and an increase in suicidal gestures over the 2020-2021 period, with rates remaining higher than in previous years. Suicide is the 2nd leading cause of death in the population aged 15-24.

Studies continue to focus on the incidence of suicidal gestures of suicidal gestures and psychological disorders, and few of them examine the factors linked to the increase in these incidences, the traumatic impact or the story of the trajectory. Similarly, the few studies focus only on the population aged 12 and over, and in some cases, do not distinguish between age groups (15-24 or under 20).

Investigators believe that the various periods of social restrictions and eco-anxiety caused by the pandemic may have influenced suicidal behaviour in this population.

The main objective of this study is to investigate the clinical and socio-economic characteristics of the pediatric population who experienced suicidal behaviors in the Auvergne Rhone Alpes region during the covid 19 pandemic.

Enrollment

6,500 estimated patients

Sex

All

Ages

8 to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • The population (subjects and controls) will be divided into age categories:

    • Pre-adolescents (≥ 8 years and < 11 years)
    • Adolescents (≥ 11 years and < 15 years)
    • Older adolescents (≥ 15 years and < 18 years)

Subjects with suicidal behavior during the health crisis (Group 1):

  • Age > 8 years and < 18 years during the period 2020 to 2022.
  • Admitted to pediatric emergency departments or hospitalized in a care unit (CHU, general hospitals) in the AURA region during 2020, 2021, and/or 2022 for suicidal behavior (defined as suicidal ideation and/or suicide attempt and/or self-harm/self-poisoning with suicidal intent).

Subjects with suicidal behavior during the health crisis with qualitative interviews (Group 1b):

  • Age > 8 years and < 18 years during the period 2020 to 2022.
  • Admitted to pediatric emergency departments or hospitalized in a care unit (CHU, general hospitals) in the AURA region during 2020, 2021, and/or 2022 for suicidal behavior (defined as suicidal ideation and/or suicide attempt and/or self-harm/self-poisoning with suicidal intent).
  • Randomly selected from the population of Group 1.
  • For whom the parent(s) and/or the subject have signed informed consent.

Controls with suicidal behavior before the health crisis (Group 2):

  • Age > 8 years and < 18 years during the period 2018 to 2019.
  • Admitted to pediatric emergency departments or hospitalized in a care unit (CHU, general hospitals) in the AURA region during 2018 and/or 2019 for suicidal behavior (defined as suicidal ideation and/or suicide attempt and/or self-harm/self-poisoning with suicidal intent).

Exclusion criteria

- Subjects with Suicidal Behavior during the Health Crisis with and without Qualitative Interviews (Group 1 and 1b):

• Admitted to pediatric emergency services or hospitalized in a healthcare facility (university hospital center, general hospital) in the AURA region for a psychiatric reason other than suicidal behavior during the period from 2020 to 2022.

Controls with Suicidal Behavior before the Health Crisis (Group 2):

  • Admitted to pediatric emergency services or hospitalized in a healthcare facility (university hospital center, general hospital) in the AURA region for a psychiatric reason other than suicidal behavior during the period from 2018 to 2019.
  • Intercurrent illness with a life expectancy of less than 24 hours.

For Group 1:

  • Pregnant, postpartum, or breastfeeding women.
  • Persons deprived of liberty by judicial or administrative decision.
  • Adults subject to a legal protection measure (guardianship, curatorship).
  • Persons not affiliated with a social security scheme or beneficiaries of a similar scheme.
  • Persons who do not understand and do not speak French.

Trial design

Primary purpose

Health Services Research

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

6,500 participants in 3 patient groups

Subjects with suicidal behaviors during the health crisis of covid-19 between 2020 and 2022 (group1)
Experimental group
Description:
* Name : Group 1 * Subjects with Suicidal Behaviors (suicidal conduct, ideas, self-harm with suicidal intention) during the Health Crisis of Covid-19 and admitted to pediatric emergency services or hospitalized in a care unit (university hospital, general hospital) in the AURA region participating between 2020 and 2022. * Age ≥ 8 years old and \< 18 years old between 2020 and 2022.
Treatment:
Other: Aggregated data collection
Subjects with suicidal behaviors during covid-19 period with qualitative interviews (group 1b)
Experimental group
Description:
* Name : Group 1b * Subjects with Suicidal Behaviors (suicidal conduct, ideas, self-harm with suicidal intention) during the Health Crisis of Covid-19 and admitted to pediatric emergency services or hospitalized in a care unit (university hospital, general hospital) in the AURA region participating between 2020 and 2022 and theirs parents * Age ≥ 8 years old and \< 18 years old between 2020 and 2022 for subjects. * One or both parents * Subjects who agreed to participate in interviews and/or focus groups and gave their consent to be part of the group of patients participating in a qualitative interview (volunteer subjects). * Parent's subjects agreed their consent to be part of the group This group is estimated to 150 subjects and 300 parents max.
Treatment:
Other: Data collection and qualitative interview
Subjects control with suicidal behaviors before the health crisis (Group 2).
Experimental group
Description:
* Name: group 2 * Subjects with suicidal behaviors (suicidal conduct, ideas, self-harm with suicidal intention) before the health crisis of Covid-19 (2018 and or 2019) and admitted to pediatric emergency services or hospitalized in a care unit (university hospital, general hospital) in the AURA region * Age ≥ 8 years old and \< 18 years old between 2018 and 2019
Treatment:
Other: Aggregated data collection

Trial contacts and locations

4

Loading...

Central trial contact

Elise MAMIMOUE, Dr; Sonia GALLETTI

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems